1. Introduction

An educational and innovation-oriented visit was conducted to the Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru. The session provided detailed insights into biotechnology innovation, startup incubation, entrepreneurship opportunities, funding mechanisms, and translational research support available for students, innovators, and startup founders.

The visit focused on understanding how C-CAMP supports research-driven innovation and facilitates the conversion of scientific ideas into commercially viable products and startups.

2. About C-CAMP

The Centre for Cellular and Molecular Platforms (C-CAMP) is a premier biotechnology innovation and incubation centre located in Bengaluru, India. It functions as a major platform supporting life science research, startup incubation, product development, and entrepreneurship.

C-CAMP aims to:

• Facilitate scientific research and technology development
• Support innovators and startups
• Promote entrepreneurship in biotechnology and healthcare sectors
• Provide incubation and translational research support
• Encourage collaborative innovation ecosystems

The organization works closely with researchers, academic institutions, startups, industries, and funding agencies

3. Key Information Shared During the Visit

3.1 Research and Innovation Support

The representatives explained that C-CAMP supports researchers and innovators who possess novel scientific ideas or research proposals with translational and commercial potential.

Key areas of support include:

• Innovation mentoring
• Startup incubation
• Networking opportunities
• Product development assistance
• Access to research infrastructure
• Entrepreneurship guidance

The session emphasized the importance of converting laboratory research into practical healthcare and biotechnology solutions

3.2 Startup and Funding Opportunities

Several funding and incubation opportunities available through C-CAMP and associated agencies were discussed.

Karnataka Startup and Biotechnology Support

The visit highlighted programs supporting:

• Startup development
• Women entrepreneurship
• Early-stage innovation projects
• Student innovators

BIRAC Support

The Biotechnology Industry Research Assistance Council (BIRAC) was discussed as a major funding agency supporting biotechnology startups and innovators.

BIRAC provides:

• Startup funding
• Innovation grants
• Incubation support
• Entrepreneurial assistance
• Product translation support

The speakers explained that applicants with innovative research proposals can apply through institutional or startup channels

3.3 Incubation Support

Information was provided regarding incubation opportunities available through C-CAMP.

The incubation ecosystem supports:

• Product conceptualization
• Prototype development
• Business mentoring
• Regulatory guidance
• Investor networking
• Startup scaling

The incubation programs generally accept applications during designated call periods

3.4 DIA Platform

The DIA platform associated with C-CAMP was discussed as a medium for innovators and researchers to connect with opportunities and innovation-related activities.

The process involves:

• Registration through mail ID
• Submission of innovative research proposals
• Interaction with innovation and startup ecosystems
• Access to incubation and mentorship opportunities

4. Student Grants and Innovation Programs

The session also covered grants and innovation opportunities available for students.

Programs mentioned included:

• Student innovation grants
• SIP grants
• Institutional innovation support
• Innovation-based competitions

The speakers encouraged students to actively participate in research translation and entrepreneurship programs.

5. BIG Grant Program

The Biotechnology Ignition Grant (BIG) program was discussed as an important funding initiative for innovators and early-stage biotechnology startups.

Important points discussed:

• BIG grants support innovative biotechnology ideas
• Applications are generally submitted through institutions or incubators
• The grant supports proof-of-concept and early product development
• C-CAMP acts as an implementation and support partner for innovators

The session highlighted that many startups have successfully benefited from this program.

6. Achievements and Impact of C-CAMP

The speakers shared several achievements associated with the innovation ecosystem.

Key highlights included:

• More than 550 patents
• More than 3000 employees associated with supported initiatives
• Multiple US-FDA approved products
• Support for more than 650 startups

These achievements demonstrate the strong impact of C-CAMP in promoting biotechnology innovation and entrepreneurship in India

7. National Bio Entrepreneurship Competition (NBEC)

Information regarding the National Bio Entrepreneurship Competition (NBEC) was also provided.

Key Details

• NBEC is a national-level biotechnology entrepreneurship competition
• The discussed edition was the 9th edition
• The competition includes two tracks:
  • Individual/Startup Track
  • Academic Track

The competition encourages students, researchers, and entrepreneurs to present innovative biotechnology ideas and business concepts.

The call for applications was mentioned to remain open until the end of May.

For Registration:

8. Learning Outcomes from the Visit

The visit provided valuable academic exposure to the biotechnology innovation and entrepreneurship ecosystem, particularly in the context of the Academic Student Track. Students gained insights into:

• Biotechnology innovation and startup ecosystems
• Academic research translation and commercialization
• Startup incubation and mentorship processes
• Funding opportunities available for students and researchers
• Student innovation grants and entrepreneurship programs
• Translational research approaches in healthcare and life sciences
• Innovation-driven career pathways in the biotechnology and pharmacy sectors

The interaction enhanced understanding of how academic research and innovative ideas can be transformed into practical healthcare solutions, translational technologies, and potential startup ventures through institutional and industry support platforms such as C-CAMP and BIRAC.

9. Conclusion

The visit to C-CAMP was highly informative and beneficial. It provided practical knowledge about innovation, entrepreneurship, startup incubation, and biotechnology funding opportunities. The session motivated students and researchers to think beyond conventional academic research and focus on translational and commercially viable innovations.

The visit also enhanced understanding of how organizations like C-CAMP and BIRAC contribute significantly toward strengthening India’s biotechnology and healthcare innovation ecosystem.

Aditya Bangalore Institute of Pharmacy Education and Research (ABIPER), in collaboration with the Indian Pharmaceutical Association (IPA), Bangalore (Urban) Local Branch, organized a seminar entitled “Integrated Drug Development and Regulatory Framework in the Pharmaceutical Industry.” The session was held at the ABIPER Seminar Hall at 11:00 AM, aimed at providing PharmD and M.Pharm students with a professional perspective on industrial drug cycles.
The event commenced with a welcome address delivered by Dr. Venkatesha, Director of ABIPER. In his opening remarks, he emphasized the importance of bridging the gap between academic curricula and industrial requirements, welcoming the guest speaker and the participating students.
The seminar was facilitated by Dr. Suresh Venkataram, a highly regarded Pharmaceutical Consultant. Dr. Venkataram brought extensive industry experience, offering technical insights into the integration of scientific research with global regulatory standards. Dr. Venkataram initiated the discussion by outlining the strategic importance of India in the global market.

• Market Growth: The Indian market was valued at approximately ₹4.7 lakh crore in 2025 and is projected to expand to ₹10 lakh crore by 2030.
• Global Supply: India currently services more than 200 countries, maintaining its status as a leader in generic drug manufacturing.

The speaker also provided a comprehensive breakdown of the drug development lifecycle, emphasizing the progression from molecular identification to clinical validation:
• Discovery Phase: Target discovery, hit generation, lead identification, and lead optimization.

• Preclinical Evaluation: Laboratory and animal testing to assess fundamental safety and biological activity.
• Clinical Trial Framework:

Phase I:Safety assessment in healthy volunteers.
Phase II: Efficacy assessment and dose optimization in patients.
Phase III: Large-scale trials to confirm effectiveness and monitor adverse reactions.

Detailed attention was given to the filing of Investigational New Drug (IND) and New Drug Application (NDA) protocols. Dr. Venkataram also addressed the high-stakes nature of the industry, noting that the average R&D cost exceeds $1.5 billion per drug with a development timeline of 8–10 years. Furthermore, the seminar covered critical formulation parameters, including:

• Physicochemical considerations: Salt selection, polymorphism, and nucleation.
• Manufacturing properties: Powder flow and drug acceptance criteria.
• Dosage selection: Tablets, capsules, ointments, and transdermal systems.

The event concluded with a high-engagement Q&A session. Dr. Venkatesha, Director of ABIPER, delivered the vote of thanks, expressing gratitude to the guest speaker for his time and to the IPA Bangalore (Urban) Local Branch for their collaboration in making the event a success. The seminar successfully enhanced the participants’ understanding of the complex intersection between scientific research and market approval.

We extend our heartfelt gratitude to Dr. Shiva Kumar Swamy, Dean of Pharmacy, RGUHS, Bangalore, Karnataka, for gracing the occasion of the Freshers’ Day celebration “GALENICALS 2026” at Aditya Bangalore Institute of Pharmacy Education and Research (ABIPER). His inspiring words on pharmacy education and the thought-provoking message drawn from the never-ending childhood story of the rabbit and mouse truly motivated and enlightened the students.

We also express our sincere thanks to Dr. Shiva Kumar Swamy Sir, CEO, ABIPER, for his timely guidance and constant support that greatly contributed to the successful completion of the Freshers’ Day celebration.

Our profound appreciation goes to our beloved Founder and Chairman of AGI and the Principal of ABIPER for their exceptional leadership, vision, and dedicated efforts in ensuring the smooth and successful conduct of this memorable event.

A special note of thanks is extended to all the students of 2nd Year D.Pharm, B.Pharm, M.Pharm, and Pharm.D for their hard work, enthusiasm, and excellent coordination in organizing various arrangements and events. Their efforts created beautiful and lasting memories for their juniors of the 2025 batch.

We would also like to sincerely thank the Freshers’ Day Celebration Coordinators, Dr. Ruhana and Ms. Yasmin, for their tireless efforts and meticulous planning. Our appreciation is equally extended to the Director Sir, AO Ma’am, and all the teaching and non-teaching staff of ABIPER for their support and cooperation in making GALENICALS 2026 a grand success.

Once again, thank you to everyone who contributed to making this celebration a wonderful and memorable occasion for our students.

Concept to Commercialization is a knowledge-driven session organized by the Institution’s Innovation Council (IIC) of Aditya Bangalore Institute of Pharmacy Education and Research (ABIPER). This program focuses on transforming innovative ideas into successful marketing solutions, guiding students and aspiring entrepreneurs through the journey from concept development to real-world commercialization. The session will be held on 28th February 2026 at 11:00 AM onwards. The expert speaker, Dr. Mahesh Matada, Technical Manager – e-Mobility & Industrial Products | LED Lighting Control, will share valuable insights on innovation strategies, product development, and market implementation. The event aims to inspire participants to convert creative ideas into impactful and commercially viable innovations.

Aditya Bangalore Institute of Pharmacy Education and Research (ABIPER) organized a comprehensive one-day seminar titled “Publishing Excellence: Research Strategy, AI Tools, Indexed Publications and Ethics” on 18th February 2026. The programme featured a panel of esteemed experts, with Dr. G. Jagadeesh, Retired Senior Expert Pharmacologist, US FDA, USA, present offline. Dr. Balakumar Pitchai and Dr. Subhada Nagarkar joined the sessions virtually during their respective time slots. The programme commenced with a formal welcome by Dr. Ruhana, Department of Pharmacy Practice. Dr. Venkatesh Venkatasubbaiah welcomed the Distinguished speaker, Dr. G. Jagadeesh, with a sapling.

Introduction of the Guest

Dr. Venkatesh Venkatasubbaiah formally introduced Dr. G. Jagadeesh, highlighting his distinguished professional journey and exemplary leadership in the global pharmaceutical sector. He described Dr. Jagadeesh as a mentor of remarkable clinical and regulatory insight, whose achievements are matched by his grounded personality and commitment to excellence. Dr. Venkatesh outlined Dr. Jagadeesh’s progression as a senior expert at the US FDA, emphasizing his extensive experience in research methodology, regulatory strategy, and the drug approval process. Key Highlights of the Seminar Dr. G. Jagadeesh, presenting in person, shared his extensive expertise on the essential building blocks of scientific inquiry, emphasizing that a high-impact publication begins long before the writing stage with a meticulously structured protocol. He detailed the logical progression from identifying a research gap to formulating a robust hypothesis, while focusing on defining clear, measurable objectives and understanding the clinical and scientific significance of the work. Drawing from his prestigious tenure at the US FDA, Dr. Jagadeesh explained how rigorous methodology at the academic level translates into global regulatory acceptance and drug approval standards.

Bridging the gap between traditional research and modern technology, Dr. Balakumar Pitchai joined the seminar virtually to demonstrate how to navigate high-impact databases such as PubMed and Scopus using advanced search strings. A major highlight of his session was the introduction of AI-based tools like Consensus AI and Scispace to streamline the literature review process, allowing researchers to synthesize vast amounts of data efficiently. He further provided a masterclass on manuscript anatomy, sharing critical strategies on title selection, abstract drafting, and adhering to journal-specific guidelines to ensure manuscripts pass the initial editorial screening and avoid desk rejection.

Following the mid-day break, Dr. G. Jagadeesh returned to focus on the post-research phase of getting work recognized globally. He advised the faculty and students on how to choose indexed journals that align with their research scope while avoiding the pitfalls of predatory publishing. He provided an insider’s view of the peer-review process, teaching participants how to address reviewer comments with professionalism and scientific rigor.

The seminar concluded with a vital session delivered virtually by Dr. Subhada Nagarkar, which served as a reminder of the moral obligations of a scientist. She provided a comprehensive overview of research misconduct, focusing on the three pillars of dishonesty: Plagiarism, Fabrication, and Falsification. Dr. Nagarkar clarified the standards for authorship assignment, warning against gift authorship and emphasizing the importance of declaring conflicts of interest to maintain transparency. The session closed with a look at the long-term damage that ethical lapses can cause to an individual’s academic credibility and the institution’s reputation, reaffirming the necessity of scientific integrity.

Interactive Session

The seminar maintained a highly engaging atmosphere through dedicated Q&A sessions held immediately following each expert’s individual presentation. The hybrid nature of the event facilitated seamless interactions, whether the speaker was present on the dais or joined virtually.

Dr. G. Jagadeesh, responding in person, provided deep insights into the expectations of global editorial boards and regulatory standards. Dr. Balakumar Pitchai and Dr. Subhada Nagarkar, joining virtually, addressed queries regarding the technical use of AI tools and the nuances of maintaining transparency and integrity throughout the submission workflow.

Felicitation and Vote of Thanks

As a token of appreciation, Dr. G. Jagadeesh was felicitated with a memento by Dr. Venkatesh Venkatasubbaiah. The session concluded with a formal Vote of Thanks, expressing heartfelt gratitude to the Chief Guest, management, faculty, organizing committee, and students for making the seminar a grand success.

Faculty Interaction Session

Following the seminar, an exclusive faculty interaction session was convened in the Board Room, providing a platform for the teaching staff to engage in a high-level dialogue with all three distinguished speakers. This session transitioned from student-centric guidance to institutional strategic planning, with the experts sharing profound insights on elevating the research profile of the college.

EVENT PHOTOSESSION